fatty-liver

Documents about fatty-liver

• A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage#900414ClinicalTrials.gov
• Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease#807168ClinicalTrials.gov
• Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial#873546ClinicalTrials.gov
• Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease#670760IRIS
• A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis#880626ClinicalTrials.gov
• A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat#979429ClinicalTrials.gov
• Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease#176312Zenodo (CERN)
• A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes#832712ClinicalTrials.gov
• Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)#853321ClinicalTrials.gov
• Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease#862059ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH#888266ClinicalTrials.gov
• Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease#8186HAL (France)
• Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD#305607PLOS
• Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver#387126ClinicalTrials.gov
• Fructose and Liver Diseases in Youth: Help Them FLY#806546ClinicalTrials.gov
• Non-Invasive Diagnostic Tests for MASLD in Pediatric Population#824882ClinicalTrials.gov
• Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD#851837ClinicalTrials.gov
• Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease#992013ClinicalTrials.gov
• Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity#160281ClinicalTrials.gov
• ACBP/DBI neutralization for the experimental treatment of fatty liver disease#185516IRIS
• Metabolic Dysfunction-Associated Fatty Liver Disease: From Pathogenesis to Treatment.#334856NCBI PubMed Central
• Anti-LPS Antibody Treatment for Pediatric NAFLD#981886ClinicalTrials.gov
• A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH#238283ClinicalTrials.gov
• Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases#845154ClinicalTrials.gov
• MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)#888435ClinicalTrials.gov
• Understanding the Role of Dietary Fatty Acids on Liver Fat Metabolism in Humans#881675ClinicalTrials.gov
• Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study#1009174ClinicalTrials.gov
• GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver#801181ClinicalTrials.gov
• ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)#807011ClinicalTrials.gov
• Effects of a Low Glycemic Load Diet on Fatty Liver in Children#125957ClinicalTrials.gov
• Weight Gain After Smoking Cessation and NAFLD#287459ClinicalTrials.gov
• The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy#373758ClinicalTrials.gov
• Glycemic Effect of Diazoxide in NAFLD#451428ClinicalTrials.gov
• PET-MR Study of Fatty Liver#833641ClinicalTrials.gov
• Diabetes Prevention and Education#886443ClinicalTrials.gov
• Observational Study About Patients Diagnosed With NAFLD#890417ClinicalTrials.gov
• Effect of Electroacupuncture on Central Obesity and Fatty Liver in Postmenopausal Women#1030791ClinicalTrials.gov
• Study to Evaluate MET642 in Patients With NASH#1032914ClinicalTrials.gov
• Serum vitamin D and lean non-alcoholic fatty liver disease: a nonlinear 'L-shaped' association in a national cross-sectional study#5125Europe PMC
• Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects#857672ClinicalTrials.gov
• A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)#835298ClinicalTrials.gov
• Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)#966746ClinicalTrials.gov
• Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease#28553ClinicalTrials.gov
• Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis#366572ClinicalTrials.gov
• The COherence of Scatter Identification and Exclusion Algorithm Study#906790ClinicalTrials.gov
• Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes#909958ClinicalTrials.gov
• Pioglitazone to Treat Fatty Liver in People With HIV Infection#868834ClinicalTrials.gov
• MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients#180285ClinicalTrials.gov
• Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis#329553ClinicalTrials.gov
• Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease#366552ClinicalTrials.gov